CINCINNATI--(BUSINESS WIRE)--Eccrine Systems, Inc. has been awarded a $3.96 million dollar contract by the United States Air Force Research Laboratory. The award is focused on the development of a next generation, non-invasive sensing system for the monitoring of specific molecular biomarkers in human sweat. Development efforts will leverage the progress of previous sweat sensing R&D projects performed in collaboration with the University of Cincinnati and the AFRL. Eccrine is partnering with UC for portions of this new project and will utilize the AFRL’s advanced testing capabilities at Wright Patterson Air Force Base in Dayton, Ohio.
“We are very pleased to be selected by the AFRL Human Effectiveness Directorate for development of this next generation sweat sensing system,” commented Robert Beech, Eccrine’s Chairman & CEO. “This important award will accelerate the development of advanced sweat sensing capabilities that are essential to the non-invasive monitoring of key physiological indicators.”
The project will start this month and continue into the latter part of 2018.
About Eccrine Systems, Inc.
Eccrine Systems is a privately held company dedicated to improving human health, safety, and productivity through the innovation and development of advanced sweat sensing technologies. The Cincinnati-based company was founded in 2013 to commercialize technology and intellectual property that was exclusively licensed from the University of Cincinnati, and with the funding support of CincyTech and its network of local, regional and national investment sources. To learn more, please visit www.eccrine.com.
Eccrine Systems, Sweatronics, and the company logo image are registered trademarks of Eccrine Systems, Inc. Other names may be trademarks of their respective owners.
Safe Harbor Statement
Some of the statements made in this press release are forward-looking statements about Eccrine Systems, Inc. These forward-looking statements are based upon the company's current expectations and projections about future events and generally relate to the company’s plans, objectives and expectations for the development of its business. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.
© 2016 Eccrine Systems, Inc. All rights reserved.
Eccrine Systems, Inc.:
Evyn White, 513-214-1659
Last updated on: 27/08/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.